Rare Biomarkers Specimen Collection And Stabilization Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Factors Are Driving the Anticipated Growth Rate of the Rare Biomarkers Specimen Collection And Stabilization Market Through 2034?
In the past few years, the market size for rare biomarkers specimen collection and stabilisation has witnessed a quick expansion. The market is projected to rise from $32.01 billion in 2024 to $35.4 billion in 2025, representing a compound annual growth rate (CAGR) of 10.6%. Factors contributing to the growth during the historical period include the human genome project, an escalation in cancer research, investments in pharmaceutical R&D, expansion of genomics and proteomics, along with bettered management of data and bioinformatics.
The market size for the collection and stabilization of rare biomarkers specimens is predicted to witness a quick surge in the upcoming years. The market is anticipated to expand to $52.46 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 10.3%. The growth predicted for this forecast period can be accredited to the enhancement of liquid biopsy applications, increase in consumer consciousness and demand, adoption of non-invasive techniques on the rise, and the discovery of biomarkers in unusual diseases. The forecast period further expects major trends such as improvements in conservation technology, growth in genomic and proteomic investigations, introduction of point-of-care testing, advancement in regulations and standardization, enhanced data analytics, and AI incorporation.
What Industry-Specific Factors Are Fueling the Growth of the Rare Biomarkers Specimen Collection And Stabilization Market?
The rise in cancer cases is anticipated to spur the expansion of the rare biomarker specimen collection and stabilization market. Cancer, characterized by the uncontrollable growth and spread of irregular cells, is becoming increasingly common due to environmental toxins and lifestyle decisions, such as smoking and unhealthy dietary habits, which aggravate inherited risks. The use of rare biomarker specimen collection and stabilization techniques in cancer incidence research allows for more precise identification and supervision of particular cancer forms, improving diagnostic and treatment strategies. For example, in October 2023, a report by the European Commission, a governing institution based in Europe, revealed that the number of new cancer cases reached 2.74 million in 2022, representing a 2.3% rise from 2020. As a result, the escalating prevalence of cancer is promoting the development of the rare biomarker specimen collection and stabilization market.
Explore Comprehensive Insights Into The Global Rare Biomarkers Specimen Collection And Stabilization Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15913&type=smp
Who Are the Major Industry Leaders Accelerating Growth in the Rare Biomarkers Specimen Collection And Stabilization Market?
Major companies operating in the rare biomarkers specimen collection and stabilization market are:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Merck KGaA
• Becton Dickinson and Company
Which Current Trends Are Having the Most Impact on the Rare Biomarkers Specimen Collection And Stabilization Market?
Key players in the rare biomarker specimen collection and stabilization market are putting their efforts into creating innovative solutions, for example, a pre-analytical platform for a fully automated process of preparing plasma and cell samples for multiomic liquid biopsy. This platform facilitates reliable, mechanized preparation of fresh samples, immediately after blood collection. It eliminates the need for special equipment or expert personnel, thereby maintaining the integrity of samples. To illustrate, in May 2022, an Italian biotech firm, Tethis S.p.A., introduced See.d, the first-ever automated, standardized pre-analytical platform. It comes with distinctive abilities such as accurate sample handling, effective separation of plasma for cellular fractions, and fixing white blood cells on SmartBioSurface slides. The platform incorporates a quality control rating mechanism to impartially assess sample stability. This method allows for systematic rating of proteomics and metabolomics data sets to evaluate the stability of plasma and serum samples.
Secure Your Global Rare Biomarkers Specimen Collection And Stabilization Market Report Now for Fast and Efficient Delivery!
Which Primary Segments of the Rare Biomarkers Specimen Collection And Stabilization Market Are Driving Growth and Industry Transformations?
The rare biomarkers specimen collection and stabilization market covered in this report is segmented –
1) By Type: Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), Circulating Tumor Cells (CTCs), Exosomes or Extracellular Vesicles
2) By Specimen: Serum Or Plasma, Other Specimens
3) By Application: Non-Invasive Prenatal Testing (NIPT), Oncology, Transcriptomics, Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular Diseases, Other Applications
4) By End-User: Hospitals, Perinatal Clinics, Public Health Labs, Private Or Commercial Labs, Physician Labs, Research Institutes, Other End-Users
Subsegments:
1) By Circulating Cell Free Deoxyribonucleic Acid (CCFDNA): Plasma CCFDNA, Serum CCFDNA
2) By Circulating Tumor Cells (CTCs): CTCs In Blood, CTCs In Bone Marrow
3) By Exosomes Or Extracellular Vesicles: Exosomes From Plasma, Exosomes From Serum
Which Regions Are Key Players in the Growth of the Rare Biomarkers Specimen Collection And Stabilization Market?
North America was the largest region in the rare biomarkers specimen collection and stabilization market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare biomarkers specimen collection and stabilization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Is the Definition of the Rare Biomarkers Specimen Collection And Stabilization Market Impacting Future Growth?
Rare biomarkers specimen collection and stabilization refers to the process of collecting and preserving biological samples containing rare or low-abundance molecules that serve as indications of specific biological processes, diseases, or situations. These biomarkers could be specific proteins, nucleic acids, metabolites, or other substances. The aim of collecting and preserving rare biomarkers is to enable accurate and reliable measurement and analysis of these molecules for diagnostic, prognostic, and therapeutic applications.
Browse Through More Similar Reports By The Business Research Company:
Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2024
Biomarkers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Cardiac Biomarkers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
